Abstract
Antibiotic resistance for many pediatric pathogens has been increasing steadily over the past decades and has complicated the antibiotic management of both community- and hospital acquired infections. This review will focus on two Gram-positive organisms- Staphylococcus aureus and Streptococcus pneumoniae and selected Gram-negative organisms that are important nosocomial organisms.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Black, S., Shinefield, H., Fireman, B., Lewis, E., Ray, P., Hansen, J.R. et al., and the Northern California Kaiser Permanente Vaccine Study Center Group. (2000). Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 19, 187–195.
Chow, J.W., Fine, M.J., Shlaes, D.M., Quinn, J.P., Hooper, D.C., Johnson, M.P. et al. (1991). Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy. Ann. Intern. Med. 115, 585–590.
Herold, B.C., Immergluck, L.C., Maranan, M.C., Lauderdale, D.S., Gaskin, R.S., Boyle-Varva, S. et al. (1998). Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. J.A.M.A. 279, 593–598.
Kaplan, S.L., Deville, J.G., Yogev, R., Morfin, M.R., Wu, E., Adler, S. et al., and the Linezolid Pediatric Study Group. (2003a). Linezolid versus vancomycin in the treatment of resistant Gram-positive infections in children. Pediatr. Infect. Dis. J. 22, 677–685.
Kaplan, S.L. and the United States Pediatric Multicenter Pneumococcal Surveillance Group. (2003b). Decline in invasive Streptococcus pneumoniae infections in eight children’s hospitals, Pediatr. Res. 53:565A. Abstract 3199.
Loeffler, A.M., Drew, R.H., Perfect, J.R., Grethe, N.I., Stephens, J.W., Gray, S.L., and Talbot, G.H. (2002). Safety and efficacy of quinupristin/dalfopristin for the treatment of invasive gram-positive infections in children. Pediatr. Infect. Dis. J. 21, 950–956.
Martinez A.G., Hammerman, W., Mason, E.O. Jr., and Kaplan, S.L. (2003). Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr. Infect. Dis. J. 7, 593–598.
Patterson, D.L., Ko W.-C., Von Gottberg, V., Casellas, J.M., Mulazimoglu, L., Klugman, K.P. et al. (2001). Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum ß-lactamases: Implications for the clinical microbiology laboratory. J. Clin. Microbiol. 39, 2206–2212.
Sattler, C.A., Mason, E.O. Jr., and Kaplan, S.L. (2002). Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr. Infect. Dis. J. 21, 910–915.
Whitney, C.G., Farley, M.M., Hadler, J., Harrison, L.H., Bennett, N.M., Lynfield, R. et al., and Schuchat, A. for the Active Bacterial Core Surveillance of the Emerging Infections Program Network. (2003). Decline in invasive pneumococcal disease after the introduction of protein-conjugate polysaccharide conjugate vaccine. N. Engl. J. Med. 348, 1737–1746.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Science+Business Media New York
About this paper
Cite this paper
Kaplan, S.L. (2004). New Antibiotics and Bacterial Resistance. In: Pollard, A.J., McCracken, G.H., Finn, A. (eds) Hot Topics in Infection and Immunity in Children. Advances in Experimental Medicine and Biology, vol 549. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8993-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8993-2_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4751-4
Online ISBN: 978-1-4419-8993-2
eBook Packages: Springer Book Archive